ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 235 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2019. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,721,000 | +59.5% | 147,060 | +29.4% | 0.01% | +42.9% |
| Q1 2021 | $1,706,000 | +679.0% | 113,613 | +646.5% | 0.01% | +600.0% |
| Q4 2020 | $219,000 | +102.8% | 15,219 | +14.4% | 0.00% | – |
| Q3 2020 | $108,000 | -20.6% | 13,300 | -33.8% | 0.00% | -100.0% |
| Q2 2020 | $136,000 | -49.4% | 20,100 | -18.1% | 0.00% | -50.0% |
| Q3 2019 | $269,000 | +131.9% | 24,532 | +145.3% | 0.00% | +100.0% |
| Q2 2019 | $116,000 | -42.0% | 10,000 | -52.4% | 0.00% | -50.0% |
| Q1 2019 | $200,000 | +852.4% | 21,000 | +1300.0% | 0.00% | – |
| Q3 2018 | $21,000 | -95.6% | 1,500 | -96.3% | 0.00% | -100.0% |
| Q2 2018 | $481,000 | +17.3% | 40,078 | +20.7% | 0.00% | 0.0% |
| Q1 2018 | $410,000 | -69.9% | 33,200 | -65.3% | 0.00% | -71.4% |
| Q3 2017 | $1,362,000 | -42.1% | 95,700 | -48.1% | 0.01% | -53.3% |
| Q2 2017 | $2,351,000 | +82.4% | 184,244 | +81.2% | 0.02% | +66.7% |
| Q1 2017 | $1,289,000 | +29.0% | 101,700 | +3.9% | 0.01% | +28.6% |
| Q4 2016 | $999,000 | -81.1% | 97,853 | -75.6% | 0.01% | -79.4% |
| Q3 2016 | $5,281,000 | +431.8% | 401,000 | +413.4% | 0.03% | +466.7% |
| Q2 2016 | $993,000 | +129.3% | 78,100 | +137.6% | 0.01% | +50.0% |
| Q1 2016 | $433,000 | -38.4% | 32,872 | -28.1% | 0.00% | -42.9% |
| Q4 2015 | $703,000 | -12.6% | 45,747 | -29.6% | 0.01% | -12.5% |
| Q3 2015 | $804,000 | +97.5% | 65,011 | +118.8% | 0.01% | +166.7% |
| Q2 2015 | $407,000 | +1528.0% | 29,710 | +1298.8% | 0.00% | – |
| Q1 2015 | $25,000 | -89.7% | 2,124 | -88.8% | 0.00% | -100.0% |
| Q4 2014 | $242,000 | +175.0% | 18,888 | +186.7% | 0.00% | +100.0% |
| Q3 2014 | $88,000 | -61.6% | 6,588 | -53.6% | 0.00% | -66.7% |
| Q2 2014 | $229,000 | -84.2% | 14,200 | -82.3% | 0.00% | -85.7% |
| Q1 2014 | $1,447,000 | +245.3% | 80,288 | +196.2% | 0.02% | +425.0% |
| Q4 2013 | $419,000 | -90.6% | 27,110 | -91.0% | 0.00% | -91.5% |
| Q3 2013 | $4,473,000 | +3690.7% | 300,800 | +3205.5% | 0.05% | +4600.0% |
| Q2 2013 | $118,000 | – | 9,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |